Srikumar Chellappan
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Mitochondrial Function and Pathology
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
- Metabolism, Diabetes, and Cancer
- RNA modifications and cancer
- Nuclear Structure and Function
Papers in
-
- Cell death mechanisms and regulation 2
- Ubiquitin and proteasome pathways 1
- Melanoma and MAPK Pathways 1
- Oncology 4
- Cancer-related Molecular Pathways 3
- Co-authors
- S. Rastogi (2 shared papers)Piyali Dasgupta (3 shared papers)Bharat Joshi (1 shared paper)Gina Fusaro (1 shared paper)Sarmistha Banerjee (1 shared paper)George R. Simon (1 shared paper)Courtney Schaal (1 shared paper)David K. Strom (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Ovarian Research (1 paper)Current Molecular Medicine (1 paper)Cancer Letters (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesPuerto RicoChina
In The Last Decade
Srikumar Chellappan
10 papers receiving 563 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 123
- Molecular Biology 388
- Oncology 115
- Cell Biology 65
- Biochemistry 18
Countries citing papers authored by Srikumar Chellappan
This map shows the geographic impact of Srikumar Chellappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikumar Chellappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikumar Chellappan more than expected).
Fields of papers citing papers by Srikumar Chellappan
This network shows the impact of papers produced by Srikumar Chellappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikumar Chellappan. The network helps show where Srikumar Chellappan may publish in the future.
Co-authors
The 25 scholars most cited alongside Srikumar Chellappan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 291 | |
| 2 | 2007 | 103 | |
| 3 | 2013 | 46 | |
| 4 | E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. | 1998 | 43 |
| 5 | 2016 | 39 | |
| 6 | 2006 | 25 | |
| 7 | 2022 | 16 | |
| 8 | 2006 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2020 | 1 |
About Srikumar Chellappan
Srikumar Chellappan is a scholar working on Molecular Biology, Oncology, Biotechnology, Psychiatry and Mental health and Cancer Research, having authored 10 papers that have together received 573 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Cancer Research and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ubiquitin and proteasome pathways (1 paper), Synthesis of Tetrazole Derivatives (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Cancer Research (123 citations), Molecular Biology (388 citations), Oncology (115 citations), Cell Biology (65 citations) and Biochemistry (18 citations). Srikumar Chellappan has collaborated with scholars based in United States, Puerto Rico and China. Frequent co-authors include S. Rastogi, Piyali Dasgupta, Bharat Joshi, Gina Fusaro, Sarmistha Banerjee, George R. Simon, Courtney Schaal, David K. Strom, John L. Cleveland and Scott W. Hiebert. Their work appears in journals such as Journal of Biological Chemistry, Journal of Ovarian Research, Current Molecular Medicine, Cancer Letters and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.